Favorable outcome with sentinel lymph node biopsy alone after neoadjuvant chemotherapy in clinically node positive breast cancer at diagnosis: Turkish Multicentric …
N Cabıoğlu, H Karanlık, N Yıldırım… - European Journal of …, 2021 - Elsevier
Purpose Factors affecting local outcome were evaluated in patients with clinically node-
positive (cN+) breast cancer at diagnosis, who underwent sentinel lymph node biopsy …
positive (cN+) breast cancer at diagnosis, who underwent sentinel lymph node biopsy …
[HTML][HTML] Uncertainties and controversies in axillary management of patients with breast cancer
WP Weber, OD Gentilini, M Morrow, G Montagna… - Cancer treatment …, 2023 - Elsevier
The aims of this Oncoplastic Breast Consortium and European Breast Cancer Research
Association of Surgical Trialists initiative were to identify uncertainties and controversies in …
Association of Surgical Trialists initiative were to identify uncertainties and controversies in …
Combining wire localization of clipped nodes with sentinel lymph node biopsy after neoadjuvant chemotherapy in node-positive breast cancer: preliminary results from …
A García-Novoa, B Acea-Nebril… - Annals of Surgical …, 2021 - Springer
Background The ideal technique for lymph node staging for patients with pathologically
confirmed node-positive breast cancer at diagnosis and neoadjuvant chemotherapy (NAC) …
confirmed node-positive breast cancer at diagnosis and neoadjuvant chemotherapy (NAC) …
Breast cancer metastasis through the lympho-vascular system
Breast cancer metastasizes through the lymphovascular system to the regional lymph nodes
in the axilla and to both visceral and non-visceral sites. Renewed interest in the route by …
in the axilla and to both visceral and non-visceral sites. Renewed interest in the route by …
Preoperative prediction nomogram based on primary tumor miRNAs signature and clinical‐related features for axillary lymph node metastasis in early‐stage invasive …
X Xie, W Tan, B Chen, X Huang, C Peng… - … journal of cancer, 2018 - Wiley Online Library
More than half patients who undergo axillary lymph node (ALN) surgery are ALN negative in
early‐stage invasive breast cancer (EIBC). Thus, to avoid excessive treatment, we aim to …
early‐stage invasive breast cancer (EIBC). Thus, to avoid excessive treatment, we aim to …
Positive ultrasound-guided lymph node needle biopsy in breast cancer may not mandate axillary lymph node dissection
CK Harris, HT Tran, K Lee, C Mylander, D Pack… - Annals of surgical …, 2017 - Springer
Abstract Background The ACOSOG Z0011 (Z11) trial demonstrated that in patients with
nonpalpable axillary lymph nodes (LN) and one to two positive sentinel LN (SLN), axillary …
nonpalpable axillary lymph nodes (LN) and one to two positive sentinel LN (SLN), axillary …
[HTML][HTML] The prognostic significance of further axillary dissection for sentinel lymph node micrometastases in female breast cancer: A competing risk analysis using the …
Y Zhou, S Pu, S Jiang, D Li, S Li, Y Liu, Y Ren… - Frontiers in …, 2022 - frontiersin.org
Background Sentinel lymph node (SLN) biopsy has been widely recognized as an excellent
surgical and staging procedure for early-stage breast cancer, and its development has …
surgical and staging procedure for early-stage breast cancer, and its development has …
Surrogate end points for overall survival in loco-regionally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis
F Rotolo, JP Pignon, J Bourhis… - JNCI: Journal of the …, 2017 - academic.oup.com
Background: The 21-gene recurrence score (RS) predicts risk of locoregional recurrence
(LRR) in node-negative, estrogen receptor (ER)–positive breast cancer. We evaluated the …
(LRR) in node-negative, estrogen receptor (ER)–positive breast cancer. We evaluated the …
Microscopic extracapsular extension in sentinel lymph nodes does not mandate axillary dissection in Z0011-eligible patients
AV Barrio, S Downs-Canner, M Edelweiss… - Annals of surgical …, 2020 - Springer
Abstract Background In the ACOSOG (American College of Surgeons Oncology Group)
Z0011 trial and the AMAROS (After Mapping of the Axilla: Radiotherapy or Surgery?) trial …
Z0011 trial and the AMAROS (After Mapping of the Axilla: Radiotherapy or Surgery?) trial …
[HTML][HTML] PPARγ agonist treatment reduces fibroadipose tissue in secondary lymphedema by exhausting fibroadipogenic PDGFRα+ mesenchymal cells
Secondary lymphedema occurs in up to 20% of patients after lymphadenectomy performed
for the surgical management of tumors involving the breast, prostate, uterus, and skin …
for the surgical management of tumors involving the breast, prostate, uterus, and skin …